Urinary Epithelial Sodium Channel (EnaC) Level as A Diabetic Marker of Nephropathy in Type 2 Diabetes Mellitus with Hypertension

Heti Kus Erni, Nina Tristina, Agnes Rengga Indrati, Dewi Kartika Turbawaty


Increased prevalence of diabetes mellitus (DM) leads to the increased of various complications including diabetic nephropathy, which can lead to the end stage renal disease (ESRD). The Epithelial sodium channel (ENaC), which is located in distal convoluted tubules, plays an important role in transepithelial sodium reabsorption for electrolyte homeostasis. Diabetes mellitus can cause changes in ENaC function which will interfere with kidney blood pressure control, worsening hypertension, and kidney injury that eventually may trigger diabetic nephropathy. The aim of this study was to determine the validity of urinary ENaC for screening diabetic nephropathy in type 2 diabetes mellitus (T2DM) with uACR as the gold standard. This was a cross-sectional analytical observational study conducted in Dr. Hasan Sadikin General Hospital Bandung, Indonesia, from December 2020 to July 2021. The subjects were 87 patients T2DM with hypertension with the majority of subjects (n=62) had a mean age of 56 years old and were experiencing albuminuria and hyperglycemia with DM for a duration of < 10 years. The poor glycemic control in these patients accelerated the occurrence of kidney damage. Result showed that urine ENaC level had a sensitivity and specificity of 82.3% and 48%, respectively, with 72.4% accuracy. The cut-off point of urine ENaC in this study was 0.98 ng/mL. Hence, urine ENaC level can be used as a test to screen for diabetic nephropathy with 82.3% sensitivity.


Diabetic nephropathy, ephitelial sodium channel (ENaC), urinary albumin-creatinine ratio (uACR)

Full Text:



Soelistijo SA, Lindarto D, Decroli E, Permana A, Sucipto K, et al. Pedoman pengelolaan dan pencegahan diabetes mellitus tipe 2 dewasa di Indonesia. Perkeni. 2019.

Spires D, Manis AD, Staruschenko A. Ion channels and transporters in diabetic kidney disease. Curr Top Membr. 2019;83:353–96.

Uwaezuoke SN. The role of novel biomarkers in predicting diabetic nephropathy: a review. Int J Nephrol Renovasc Dis. 2017;10:221–31.

Unruh ML, Pankratz VS, Demko JE, Ray EC, Hughey RP, et al. Trial of amiloride in type 2 diabetes with proteinuria. Kidney Int Rep. 2017;2(5):893–904.

Eriguchi M, Bernstein EA, Veiras LC, Khan Z, Cao DY, et al. The absence of the ACE N-domain decreases renal inflammation and facilitates sodium excretion during diabetic kidney disease. J Am Soc Nephrol. 2018;29(10):2546–61.

Campion CG, Sanchez-Ferras O, Batchu SN. Potential role of serum and urinary biomarkers in diagnosis and prognosis of diabetic nephropathy. Can J Kidney Health Dis. 2017;4:2054358117705371.

Williams TA, Reincke M. Management of endocrine disease: diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited. Eur J Endocrinol. 2018;179(1):R19–29.

Cloune Clode Corp. Enzyme-linked immunosorbent assay kit for amiloride sensitive sodium channel subunit alpha (SCNN1a). 2013.

Dawson B, Trapp RG. Basic & Clinical Biostatistics, 4th Edition. 4th ed. In: Foltin J, Lebowitz H, Fernando N, editors. Physics. Illinois: McGraw-Hill Education; 2004.

Shamsirgaran SM, Mamaghanian A, Aliasgarzadeh A, Aiminisani N, Alamdari MI. Age differences in diabetes-related complication and glycemic control. BMC Endocri Disorders. 2017:17(25):1-7.

Fasil A, Biadgo B, Abebe M. Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2018;12:75–83.

American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care. 2020.43(1):S14–31.

Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am. 2014;43(1):103–22.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Clinical practice guideline for the management of blood pressure in chronic kidney disease. KDIGO. 2013;3(1):1–163.

Zheng H, Liu X, Sharma NM, Li Y, Pliquett RU, et al. urinary proteolytic activation of renal epithelial na+ channels in chronic heart failure. Hypertension. 2016;67(1):197–20

DOI: https://doi.org/10.15395/mkb.v54n1.2533

Article Metrics

Abstract view : 289 times
PDF - 299 times

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Creative Commons License
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License


View My Stats